The triple-negative breast carcinoma (TNBC) is the most aggressive subtype of breast cancer, which is characterized by lack expression of estrogen receptor (ER) and progesterone receptor (PR), and non-amplification of human epidermal growth factor receptor 2 (HER2)1,2. This evidence concerns the gene ESR1 and breast cancer.